Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Withdrawn 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Neoplasms 14Lung Neoplasms 11Colonic Neoplasms 9Breast Neoplasms 9Brain Neoplasms 7Prostatic Neoplasms 4Emergence Delirium 4Urinary Bladder Neoplasms 3Stomach Neoplasms 3Rectal Neoplasms 3Pituitary Neoplasms 3Neoplastic Cells, Circulating 3Carcinoma, Non-Small-Cell Lung 3Carcinoma, Hepatocellular 3Agnosia 3Supratentorial Neoplasms 2Respiratory Aspiration 2Postoperative Complications 2Pain, Postoperative 2Ovarian Neoplasms 2Neoplasm Metastasis 2Melanoma 2Liver Neoplasms 2Hypoxia 2Delirium 2Colorectal Neoplasms 2Abdominal Neoplasms 2Uterine Neoplasms 1Tuberculosis, Pulmonary 1Thyroid Nodule 1

Interventions

Sevoflurane 1Propofol 1Melatonin 1Fentanyl 1Atracurium 1Antineoplastic Agents, Hormonal 1Acupuncture Therapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Female Breast Cancer × Propofol × Clear all
NCT03005860 2023-12-21

Effect of TIVA Propofol vs Sevoflurane Anaesthetic on Serum Biomarkers and on PBMCs in Breast Cancer Surgery

Tata Memorial Centre

Phase NA Withdrawn
Breast

Female Breast Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡